View Older Stories

Dec 17, 2025 04:31AM Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)

Dec 16, 2025 11:04AM Nektar Therapeutics (NKTR) PT Raised to $115 at Oppenheimer

Dec 16, 2025 07:30AM Nektar reports mixed phase 2b results for alopecia areata drug

Dec 16, 2025 07:25AM Nektar Therapeutics (NKTR) Halted, News Pending

Nov 24, 2025 05:35AM Nektar Therapeutics (NKTR) PT Raised to $121 at Jefferies

Nov 12, 2025 04:34PM Nektar Therapeutics enters $110 million equity distribution agreement

Nov 10, 2025 03:05AM Oppenheimer Reiterates Outperform Rating on Nektar Therapeutics (NKTR)

Nov 6, 2025 05:15PM Nektar Therapeutics (NKTR) Tops Q3 EPS by 185c

Oct 24, 2025 09:52AM Nektar Therapeutics (NKTR) on Watch Following M&A Chatter

Oct 17, 2025 02:05PM Nektar Therapeutics (NKTR) PT Raised to $105 at B.Riley

Oct 17, 2025 01:32PM Nektar Therapeutics (NKTR) Strength Attributed to Rumor

Sep 18, 2025 03:48PM Nektar Therapeutics (NKTR) PT Raised to $99 at Jefferies

Sep 18, 2025 08:46AM Nektar presents positive Phase 2b atopic dermatitis trial results

Sep 15, 2025 08:32AM Piper Sandler on Nektar Therapeutics (NKTR): 'A Perfect Opportunity to Own NKTR Ahead of Additional AD Data'

Sep 4, 2025 03:39PM Analysts postive on Nektar opportunity after Sanofi data

Aug 7, 2025 04:29PM Nektar Therapeutics (NKTR) Misses Q2 EPS by 258c

Jul 29, 2025 09:01AM Nektar receives FDA fast track for alopecia areata treatment

Jul 1, 2025 07:18AM Nektar Therapeutics (NKTR) Prices 4.26M Share Offering at $23.50/sh

Jun 30, 2025 04:03PM Nektar Therapeutics (NKTR) Announces Proposed Public Offering

Jun 25, 2025 03:20PM Nektar Therapeutics (NKTR) call put ratio 1 call to 1 put on 15K contracts as share price up 24%

Jun 25, 2025 06:39AM Nektar Therapeutics (NKTR) PT Raised to $120 at H.C. Wainwright

Jun 25, 2025 04:56AM Increasing unusual option volume: NKTR RGLS PAGS ASTL NTS HUYA PAYX EWY

Jun 24, 2025 03:41PM Nektar Therapeutics (NKTR) PT Raised to $69 at Jefferies, 'data update gives us further confidence in Rezpeg's potential'

Jun 24, 2025 01:11PM Nektar Therapeutics (NKTR) PT Raised to $100 at BTIG, 'We see NKTR as a "pound the table BUY"'

Jun 24, 2025 10:45AM Increasing unusual option volume: NKTR PAGS GXO SFIX HUYA NTS RZLV MAIN COTY

Jun 24, 2025 07:40AM Nektar Therapeutics (NKTR) to Resume Trading at 8 am

Jun 24, 2025 07:31AM Nektar Therapeutics (NKTR): REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe AD

Jun 24, 2025 07:00AM Nektar Therapeutics (NKTR) Halted, News Pending

Jun 23, 2025 04:31PM Nektar Therapeutics (NKTR) to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin, a Regulatory T-cell Proliferator, in Atopic Dermatitis on June

May 12, 2025 07:03AM H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)

May 9, 2025 05:30AM BTIG Reiterates Buy Rating on Nektar Therapeutics (NKTR)

May 8, 2025 04:43PM Nektar Therapeutics (NKTR) Misses Q1 EPS by 8c

Apr 11, 2025 05:09AM Jefferies Upgrades Nektar Therapeutics (NKTR) to Buy

Mar 28, 2025 04:24PM Nektar Therapeutics (NKTR) Files $300M Mixed Shelf

Mar 14, 2025 01:55AM Oppenheimer Upgrades Nektar Therapeutics (NKTR) to Outperform

Mar 13, 2025 04:46AM BTIG Reiterates Neutral Rating on Nektar Therapeutics (NKTR)

Mar 13, 2025 04:34AM Nektar Therapeutics (NKTR) PT Lowered to $1 at Jefferies

Mar 12, 2025 04:17PM Nektar Therapeutics (NKTR) Tops Q4 EPS by 19c

Feb 26, 2025 07:01AM Nektar Therapeutics (NKTR) Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin

Feb 25, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Nektar Therapeutics (NKTR)

Feb 24, 2025 11:29PM Piper Sandler Reiterates Overweight Rating on Nektar Therapeutics (NKTR)

Feb 24, 2025 07:00AM Nektar Therapeutics (NKTR) Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

Feb 10, 2025 07:01AM Nektar Therapeutics (NKTR) Receives Fast Track Designation for Rezpegaldesleukin

Jan 10, 2025 07:03AM Nektar Therapeutics (NKTR) competes target enrollment in its REZOLVE-AD Phase 2b study

Jan 7, 2025 11:35PM B.Riley Starts Nektar Therapeutics (NKTR) at Buy

Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies

Dec 10, 2024 06:36AM H.C. Wainwright Starts Nektar Therapeutics (NKTR) at Buy

Nov 7, 2024 04:32PM Nektar Therapeutics (NKTR) Tops Q3 EPS by 2c

Nov 7, 2024 10:16AM Nektar Therapeutics (NKTR) and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255

Nov 4, 2024 08:30AM Nektar Therapeutics (NKTR) to Sell Commercial PEGylation Reagent Manufacturing Business in Alabama

View Older Stories